Xenon

CHEMBL1236802 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
131.3 g/mol
LogP
Phase
4

Xenon is a noble gas that produces general anesthesia through NMDA receptor antagonism and potassium channel activation, with additional neuroprotective properties attributed to NMDA blockade and HIF-1alpha activation. It is used clinically as an inhalation anesthetic in some European countries, offering advantages including rapid induction and recovery, cardiovascular stability, and absence of hepatotoxicity, and has been investigated for neuroprotection in ischemia-reperfusion injury and asphyxia. As a radioactive isotope (133Xe), it is used in pulmonary ventilation scintigraphy.

Masse moléculaire

131,2900 g/mol

TPSA

0,00 Ų

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[Xe]

InChI

InChI=1S/Xe

Molecular Formula

Xe

HBD / HBA

- / -

Liaisons Rotatives

0

Atomes Lourds

1

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Xenon is a noble gas that produces general anesthesia through NMDA receptor antagonism and potassium channel activation, with additional neuroprotective properties attributed to NMDA blockade and HIF-1alpha activation. It is used clinically as an inhalation anesthetic in some European countries, offering advantages including rapid induction and recovery, cardiovascular stability, and absence of hepatotoxicity, and has been investigated for neuroprotection in ischemia-reperfusion injury and asphyxia. As a radioactive isotope (133Xe), it is used in pulmonary ventilation scintigraphy.

Yes, Xenon is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1236802. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23991. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.